GAPDHS: A Potential Drug Target for Energy and Blood Sugar Regulation

Target Name: GAPDHS

NCBI ID: G26330

GAPDHS

GAPDHS: A Potential Drug Target for Energy and Blood Sugar Regulation

Glyceraldehyde-3-phosphate dehydrogenase (GAPDHS) is a protein that is expressed in various tissues and cells in the body, including the brain, heart, and kidneys. It is a key enzyme in the glyceraldehyde pathway, a critical metabolic pathway that is involved in the production of energy from glucose.

GAPDHS is a protein that is composed of four subunits, which are encoded by the genes GAPDHS1, GAPDHS2, GAPDHS3, and GAPDHS4. The GAPDHS1 subunit is responsible for catalyzing the first step of the glyceraldehyde pathway, while the other subunits are involved in the subsequent steps.

GAPDHS is a critical enzyme that is involved in the production of ATP, which is the energy currency of the cell. It is also involved in the production ofNADH, which is a critical co-factor for various enzymes that participate in the detoxification of harmful substances in the body.

GAPDHS is also involved in the production of glucose, which is the body's main source of energy. It is part of a complex metabolic pathway that is responsible for maintaining the brain's energy supply, and it is also involved in the production of insulin, which is critical for the regulation of blood sugar levels.

GAPDHS is a protein that is expressed in various tissues and cells in the body, including the brain, heart, and kidneys. It is a key enzyme in the glyceraldehyde pathway, a critical metabolic pathway that is involved in the production of energy from glucose.

GAPDHS is a potential drug target, as it is involved in the production of ATP, NADH, and glucose, which are all critical for the function of the body. It is also involved in the production of insulin, which is critical for the regulation of blood sugar levels.

GAPDHS is a protein that is expressed in various tissues and cells in the body, including the brain, heart, and kidneys. It is a key enzyme in the glyceraldehyde pathway, a critical metabolic pathway that is involved in the production of energy from glucose.

GAPDHS is a potential drug target, as it is involved in the production of ATP, NADH, and glucose, which are all critical for the function of the body. It is also involved in the production of insulin, which is critical for the regulation of blood sugar levels.

GAPDHS is a protein that is expressed in various tissues and cells in the body, including the brain, heart, and kidneys. It is a key enzyme in the glyceraldehyde pathway, a critical metabolic pathway that is involved in the production of energy from glucose.

GAPDHS is a potential drug target, as it is involved in the production of ATP, NADH, and glucose, which are all critical for the function of the body. It is also involved in the production of insulin, which is critical for the regulation of blood sugar levels.

GAPDHS is a protein that is expressed in various tissues and cells in the body, including the brain, heart, and kidneys. It is a key enzyme in the glyceraldehyde pathway, a critical metabolic pathway that is involved in the production of energy from glucose.

GAPDHS is a potential drug target, as it is involved in the production of ATP, NADH, and glucose, which are all critical for the function of the body. It is also involved in the production of insulin, which is critical for the regulation of blood sugar levels.

GAPDHS is a protein that is expressed in various tissues and cells in the body, including the brain, heart, and kidneys. It is a key enzyme in the glyceraldehyde pathway, a critical metabolic pathway that is involved in the production of energy from glucose.

GAPDHS is a potential drug target, as it is involved in the production of ATP, NADH, and glucose, which are all critical for the function of the body. It is also involved in the production of insulin, which is critical for the regulation of blood sugar levels.

GAPDHS is a protein that is expressed in various tissues and cells in the body, including the brain, heart, and kidneys. It is a key enzyme in the glyceraldehyde pathway, a critical metabolic pathway that is involved in the production of energy from glucose.

GAPDHS is a potential drug target, as it is involved in the production of ATP, NADH, and glucose, which are all critical for the function of the body. It is also involved in the production of insulin, which is critical for the regulation of blood sugar levels.

GAPDHS is a protein that is expressed in various tissues and cells in the body, including the brain, heart, and kidneys. It is a key enzyme in the glyceraldehyde pathway, a critical metabolic pathway that is involved in the production of energy from glucose.

GAPDHS is a potential drug target, as it is involved in the production of ATP, NADH, and glucose, which are all critical for the function of the body. It is also involved in the production of insulin, which is critical for the regulation of blood sugar levels.

GAPDHS is a protein that is expressed in various tissues and cells in the body, including the brain, heart, and kidneys. It is a key enzyme in the glyceraldehyde pathway, a critical metabolic pathway that is involved in the production of energy from glucose.

GAPDHS is a potential drug target, as it is involved in the production of ATP, NADH, and glucose, which are all critical for the function of the body. It is also involved in the production of insulin, which is critical for the regulation of blood sugar levels.

GAPDHS is a protein that is expressed in various tissues and cells in the body, including the brain, heart, and kidneys. It is a key enzyme in the glyceraldehyde pathway, a critical metabolic pathway that is involved in the production of energy from glucose.

GAPDHS is a potential drug target, as it is involved in the production of ATP, NADH, and glucose, which are all critical for the function of the body. It is also involved in the production of insulin, which is critical for the regulation of blood sugar levels.

GAPDHS is a protein that is expressed in various tissues and cells in the body, including the brain, heart, and kidneys. It is a key enzyme in the glyceraldehyde pathway, a critical metabolic pathway that is involved in the production of energy from glucose.

GAPDHS is a potential drug target, as it is involved in the production of ATP, NADH, and glucose, which are all critical for the function of the body. It is also involved in the production of insulin, which is critical for the regulation of blood sugar levels.

GAPDHS is a protein that is expressed in various tissues and cells in the body, including the brain, heart, and kidneys. It is a key enzyme in the glyceraldehyde pathway, a critical metabolic pathway that is involved in the production of energy from glucose.

GAPDHS is a potential drug target, as it is involved in the production of ATP, NADH, and glucose, which are all critical for the function of the body. It is also involved in the production of insulin, which is critical for the regulation of blood sugar levels.

GAPDHS is a protein that is expressed in various tissues and cells in the body, including the brain, heart, and kidneys. It is a key enzyme in the glyceraldehyde pathway, a critical metabolic pathway that is involved in the production of energy from glucose.

GAPDHS is a potential drug target, as it is involved in the production of ATP, NADH, and glucose, which are all critical for the function of the body. It is also involved in the production of insulin, which is critical for the regulation of blood sugar levels.

GAPDHS is a protein that is expressed in various tissues and cells in the body, including the brain, heart, and kidneys. It is a key enzyme in the glyceraldehyde pathway, a critical metabolic pathway that is involved in the production of energy from glucose.

GAPDHS is a potential drug target, as it is involved in the production of ATP, NADH, and glucose, which are all critical for the function of the body. It is also involved in the production of insulin, which is critical for the regulation of blood sugar levels.

GAPDHS is a protein that is expressed in various tissues and cells in the body, including the brain, heart, and kidneys. It is a key enzyme in the glyceraldehyde pathway, a critical metabolic pathway that is involved in the production of energy from glucose.

GAPDHS is a potential drug target, as it is involved in the production of ATP

Protein Name: Glyceraldehyde-3-phosphate Dehydrogenase, Spermatogenic

Functions: May play an important role in regulating the switch between different pathways for energy production during spermiogenesis and in the spermatozoon. Required for sperm motility and male fertility (By similarity)

The "GAPDHS Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about GAPDHS comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets